Anandamide membrane transport inhibitor (IC50 = 14 ?M) that is relatively metabolically stable. Displays some affinity for CB2 receptors but has only weak affinity for CB1 receptors and has no activit
y at VR1 receptors or FAAH. Anticonvulsive in vivo following systemic administration. Tocris Bioscience1481

Anandamide membrane transport inhibitor (IC50 = 14 ?M) that is relatively metabolically stable. Displays some affinity for CB2 receptors but has only weak affinity for CB1 receptors and has no activity at VR1 receptors or FAAH. Anticonvulsive in vivo following systemic administration. Tocris Bioscience1481

Anandamide membrane transport inhibitor (IC50 = 14 muM) that is relatively metabolically stable. Displays some affinity for CB2 receptors but has only weak affinity for CB1 receptors and has no activity at VR1 receptors or FAAH. Anticonvulsive in vivo following systemic administration. Tocris Bioscience1481